Sfoglia per Corso
Mostrati risultati da 1 a 13 di 13
Assessment of Cardiovascular Risk by Coronary Calcium Score in Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease
2023/2024 FRIZZERA, FRANCESCA
Blood cell profiling distinguishes disease states and detects residual immune activation in ANCA-associated vasculitis
2023/2024 DAVANZO, FEDERICA
Discovery and validation of novel biomarkers for diagnosis and outcome of autoimmune diseases: anti-LIN28A IgG and IgA antibodies are highly specific for Systemic Lupus Erythematosus and are associated with histological activity and treatment response in Lupus Nephritis.
2022/2023 CRUCIANI, CLAUDIO
Effectiveness and safety of rituximab in patients with refractory idiopathic inflammatory myopathies: a retrospective study from a single-center cohort with a special focus on low-dose as a maintenance treatment for remission.
2022/2023 GAMBA, ANNA
Efficacy and safety of Extended-Interval Rituximab vs. Standard MAINRITSAN Regimen for remission Maintenance in ANCA-Associated Vasculitis: A Multicenter Study
2021/2022 CAMPANIELLO, DEBORA
Efficacy of belimumab in SLE with hematological manifestations: retrospective analysis from the BeRLiSS-JS cohort
2022/2023 ARRU, FEDERICO
EVALUATION OF GLUCOCORTICOID WITHDRAWAL DURING REMISSION IN SYSTEMIC LUPUS ERYTHEMATOSUS
2022/2023 VESENTINI, FILIPPO
IL-5 Pathway Inhibition in EGPA: Real-World Comparative, Multidimensional Assessment of Mepolizumab and Benralizumab
2023/2024 CODIRENZI, MARTA
PROGNOSTIC FACTORS IN PATIENTS WITH ANTI-MDA5 ANTIBODY-POSITIVE DERMATOMYOSITIS: RETROSPECTIVE DATA ANALYSIS FROM TWO ITALIAN COHORTS
2023/2024 PETTOROSSI, FEDERICO
Secondary Antiphospholipid Syndrome in Patients with Systemic Lupus Erythematosus: A Clinical and Laboratory Analysis of a Monocentric Cohort in Light of the 2023 ACR/EULAR Classification Criteria
2023/2024 RAHMÉ, ZAHRÀ
Significato clinico degli anticorpi anti-proteina arginina metiltransferasi 5 (PRMT5) nei pazienti affetti da sclerosi sistemica
2023/2024 BINDA, MARCO
Synovial Markers in Refractory Rheumatoid Arthritis: Distinguishing Non-Inflammatory and Persistent Inflammatory Phenotypes
2022/2023 SALVATO, MARIANGELA
Unveiling the Unseen Signals: Identifying Novel Diagnostic and Prognostic Biomarkers for Eosinophilic Granulomatosis with Polyangiitis
2022/2023 IORIO, LUCA
| Tipologia | Anno | Titolo | Titolo inglese | Autore | File |
|---|---|---|---|---|---|
| Scuole di Specializzazione | 2023 | Assessment of Cardiovascular Risk by Coronary Calcium Score in Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease | Assessment of Cardiovascular Risk by Coronary Calcium Score in Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease | FRIZZERA, FRANCESCA | |
| Scuole di Specializzazione | 2023 | Blood cell profiling distinguishes disease states and detects residual immune activation in ANCA-associated vasculitis | Blood cell profiling distinguishes disease states and detects residual immune activation in ANCA-associated vasculitis | DAVANZO, FEDERICA | |
| Scuole di Specializzazione | 2022 | Discovery and validation of novel biomarkers for diagnosis and outcome of autoimmune diseases: anti-LIN28A IgG and IgA antibodies are highly specific for Systemic Lupus Erythematosus and are associated with histological activity and treatment response in Lupus Nephritis. | Discovery and validation of novel biomarkers for diagnosis and outcome of autoimmune diseases: anti-LIN28A IgG and IgA antibodies are highly specific for Systemic Lupus Erythematosus and are associated with histological activity and treatment response in Lupus Nephritis. | CRUCIANI, CLAUDIO | |
| Scuole di Specializzazione | 2022 | Effectiveness and safety of rituximab in patients with refractory idiopathic inflammatory myopathies: a retrospective study from a single-center cohort with a special focus on low-dose as a maintenance treatment for remission. | Effectiveness and safety of rituximab in patients with refractory idiopathic inflammatory myopathies: a retrospective study from a single-center cohort with a special focus on low-dose as a maintenance treatment for remission. | GAMBA, ANNA | |
| Scuole di Specializzazione | 2021 | Efficacy and safety of Extended-Interval Rituximab vs. Standard MAINRITSAN Regimen for remission Maintenance in ANCA-Associated Vasculitis: A Multicenter Study | Efficacy and safety of Extended-Interval Rituximab vs. Standard MAINRITSAN Regimen for remission Maintenance in ANCA-Associated Vasculitis: A Multicenter Study | CAMPANIELLO, DEBORA | |
| Scuole di Specializzazione | 2022 | Efficacy of belimumab in SLE with hematological manifestations: retrospective analysis from the BeRLiSS-JS cohort | Efficacy of belimumab in SLE with hematological manifestations: retrospective analysis from the BeRLiSS-JS cohort | ARRU, FEDERICO | |
| Scuole di Specializzazione | 2022 | EVALUATION OF GLUCOCORTICOID WITHDRAWAL DURING REMISSION IN SYSTEMIC LUPUS ERYTHEMATOSUS | EVALUATION OF GLUCOCORTICOID WITHDRAWAL DURING REMISSION IN SYSTEMIC LUPUS ERYTHEMATOSUS | VESENTINI, FILIPPO | |
| Scuole di Specializzazione | 2023 | IL-5 Pathway Inhibition in EGPA: Real-World Comparative, Multidimensional Assessment of Mepolizumab and Benralizumab | IL-5 Pathway Inhibition in EGPA: Real-World Comparative, Multidimensional Assessment of Mepolizumab and Benralizumab | CODIRENZI, MARTA | |
| Scuole di Specializzazione | 2023 | PROGNOSTIC FACTORS IN PATIENTS WITH ANTI-MDA5 ANTIBODY-POSITIVE DERMATOMYOSITIS: RETROSPECTIVE DATA ANALYSIS FROM TWO ITALIAN COHORTS | PROGNOSTIC FACTORS IN PATIENTS WITH ANTI-MDA5 ANTIBODY-POSITIVE DERMATOMYOSITIS: RETROSPECTIVE DATA ANALYSIS FROM TWO ITALIAN COHORTS | PETTOROSSI, FEDERICO | |
| Scuole di Specializzazione | 2023 | Secondary Antiphospholipid Syndrome in Patients with Systemic Lupus Erythematosus: A Clinical and Laboratory Analysis of a Monocentric Cohort in Light of the 2023 ACR/EULAR Classification Criteria | Secondary Antiphospholipid Syndrome in Patients with Systemic Lupus Erythematosus: A Clinical and Laboratory Analysis of a Monocentric Cohort in Light of the 2023 ACR/EULAR Classification Criteria | RAHMÉ, ZAHRÀ | |
| Scuole di Specializzazione | 2023 | Significato clinico degli anticorpi anti-proteina arginina metiltransferasi 5 (PRMT5) nei pazienti affetti da sclerosi sistemica | Anti-Protein Arginine Methyltransferase 5 (PRMT5) Antibodies in the Assessment of Patients with Systemic Sclerosis | BINDA, MARCO | |
| Scuole di Specializzazione | 2022 | Synovial Markers in Refractory Rheumatoid Arthritis: Distinguishing Non-Inflammatory and Persistent Inflammatory Phenotypes | Synovial Markers in Refractory Rheumatoid Arthritis: Distinguishing Non-Inflammatory and Persistent Inflammatory Phenotypes | SALVATO, MARIANGELA | |
| Scuole di Specializzazione | 2022 | Unveiling the Unseen Signals: Identifying Novel Diagnostic and Prognostic Biomarkers for Eosinophilic Granulomatosis with Polyangiitis | Unveiling the Unseen Signals: Identifying Novel Diagnostic and Prognostic Biomarkers for Eosinophilic Granulomatosis with Polyangiitis | IORIO, LUCA |
Mostrati risultati da 1 a 13 di 13
Legenda icone
- file ad accesso aperto
- file ad accesso riservato
- file sotto embargo
- nessun file disponibile